Patent ID: 9575074
Date: 2017-02-21
CPC Classifications: A61B,G01N

Claim:
1. An apparatus for evaluating an atherosclerotic lesion at the initial or the intermediate stage, comprising: (i) a means of detecting plastin-2 in a subject; (ii) a means of detecting at least one type of protein selected from each of group (a), (b), (c), and (d) from among proteins shown in the following groups (a) to (d), in a subject: (iii) a means of evaluating the atherosclerotic lesion at the initial or the intermediate stage in the subject based on the detection results obtained by means (i) and (ii); wherein the apparatus comprises at least one of the following to detect the plastin-2: positron emission tomography (PET), single photon emission computed tomography (SPECT), γ scintigraphy, autoradiography, fluorescent imaging, magnetic resonance imaging (MRI), ultrasonication, and computed tomography (CT), a biosensor, a solid-phase support to which an antibody against a marker has been immobilized, mass spectoscropy, a surface plasmon resonance sensor, and an NMR analyzer; and wherein the apparatus further comprises at least one of the following to evaluate the atherosclerotic lesion: an image-numeric data storage part, standard level data storage part, a data comparison part and a data analysis part for analysis of data, data output-display part, a software and a computer unit for activating a computer part.